Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells.
New findings from a Giellepi Health Science Division clinical research trial demonstrates that a mixture of probiotic strains and lactoferrin could aid in reducing the most common cause of vaginal discomfort in women.
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities in San Diego, California.
Eisai Co., Ltd and University College London announced that they have commenced preparations for Phase I clinical studies on E2814
ADC Biotechnology , announces that it has secured additional funding of £2.5 million from existing investors and company management.